Dasatinib + Quercetin (D+Q)
Research / preclinicalMayo Clinic senolytic combo — removes senescent cells.
Mechanism
Senolytic combination. Mayo Clinic senolytic combo — removes senescent cells. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.
Peer-Reviewed Studies (2)
Senolytics Decrease Senescent Cells in Humans (D+Q Trial)
First human trial of D+Q in IPF; reduced senescent cell burden.
PubMed PMID 30616998 →Senolytics in Diabetic Kidney Disease
D+Q reduced senescence markers in DKD patients.
PubMed PMID 31542391 →